These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 34075562)

  • 1. The Effect of COVID-19 on NF-κB and Neurological Manifestations of Disease.
    Davies DA; Adlimoghaddam A; Albensi BC
    Mol Neurobiol; 2021 Aug; 58(8):4178-4187. PubMed ID: 34075562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Nuclear Factor Kappa B (NF-κB) in Development and Treatment of COVID-19: Review.
    Gudowska-Sawczuk M; Mroczko B
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients.
    Hariharan A; Hakeem AR; Radhakrishnan S; Reddy MS; Rela M
    Inflammopharmacology; 2021 Feb; 29(1):91-100. PubMed ID: 33159646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article.
    Taher T; Sheikh AB; Anwar F; Khosa F
    Acta Neurol Belg; 2021 Apr; 121(2):331-339. PubMed ID: 33464546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological Associations of SARS-CoV-2 Infection: A Systematic Review.
    Javed A
    CNS Neurol Disord Drug Targets; 2022; 21(3):246-258. PubMed ID: 33593267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 and Neurological Impairment: Hypothalamic Circuits and Beyond.
    Mussa BM; Srivastava A; Verberne AJM
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33802995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches.
    Mahboubi Mehrabani M; Karvandi MS; Maafi P; Doroudian M
    Rev Med Virol; 2022 Nov; 32(6):e2334. PubMed ID: 35138001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological Involvement in COVID-19 and Potential Mechanisms: A Review.
    Aghagoli G; Gallo Marin B; Katchur NJ; Chaves-Sell F; Asaad WF; Murphy SA
    Neurocrit Care; 2021 Jun; 34(3):1062-1071. PubMed ID: 32661794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging neurotropic features of SARS-CoV-2.
    Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
    J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological Symptoms of COVID-19: The Zonulin Hypothesis.
    Llorens S; Nava E; Muñoz-López M; Sánchez-Larsen Á; Segura T
    Front Immunol; 2021; 12():665300. PubMed ID: 33981312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 ORF3a-Mediated NF-κB Activation Is Not Dependent on TRAF-Binding Sequence.
    Busscher BM; Befekadu HB; Liu Z; Xiao TS
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-induced liquid phase separation of SARS-CoV-2 nucleocapsid protein facilitates NF-κB hyper-activation and inflammation.
    Wu Y; Ma L; Cai S; Zhuang Z; Zhao Z; Jin S; Xie W; Zhou L; Zhang L; Zhao J; Cui J
    Signal Transduct Target Ther; 2021 Apr; 6(1):167. PubMed ID: 33895773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological symptoms as a clinical manifestation of coronavirus disease 2019: implications for internists.
    Adamczyk-Sowa M; Niedziela N; Kubicka-Bączyk K; Wierzbicki K; Jaroszewicz J; Sowa P
    Pol Arch Intern Med; 2021 Jan; 131(1):54-62. PubMed ID: 32820884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological manifestations of COVID-19: with emphasis on Iranian patients.
    Aslan C; Nikfarjam S; Asadzadeh M; Jafari R
    J Neurovirol; 2021 Apr; 27(2):217-227. PubMed ID: 33710597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
    Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
    Front Immunol; 2021; 12():749291. PubMed ID: 34867978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19.
    Maiese A; Manetti AC; Bosetti C; Del Duca F; La Russa R; Frati P; Di Paolo M; Turillazzi E; Fineschi V
    Brain Pathol; 2021 Nov; 31(6):e13013. PubMed ID: 34390282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological Sequelae of COVID-19.
    Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
    J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms.
    Johansson A; Mohamed MS; Moulin TC; Schiöth HB
    J Neuroimmunol; 2021 Sep; 358():577658. PubMed ID: 34304141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of COVID-19 and neurological complications.
    Hosseini N; Nadjafi S; Ashtary B
    Rev Neurosci; 2021 Aug; 32(6):671-691. PubMed ID: 33583157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.